Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 26 1 2022
medline: 21 4 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

Few data exist concerning circulating tumor DNA (ctDNA) relevance in primary mediastinal B-cell lymphoma (PMBL). To explore this topic, we applied a 9-gene next-generation sequencing pipeline to samples from forty-four PMBL patients (median age 36.5 years). The primary endpoint was a similarity between paired biopsy/plasma mutational profiles. We detected at least one variant in 32 plasma samples (80%). The similarity between the biopsy and ctDNA genetic profiles for the 30 patients with paired mutated biopsy/plasma samples was greater than or equal to 80% in 19 patients (63.3%). We then compared PMBL ctDNA features with those of a cohort of Hodgkin lymphoma patients (

Identifiants

pubmed: 35075971
doi: 10.1080/10428194.2021.2010060
doi:

Substances chimiques

Circulating Tumor DNA 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

834-844

Commentaires et corrections

Type : CommentIn

Auteurs

Vincent Camus (V)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Mathieu Viennot (M)

INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Emilie Lévêque (E)

Clinical Research Unit, Centre Henri Becquerel, Rouen, France.

Pierre-Julien Viailly (PJ)

INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

David Tonnelet (D)

Department of Nuclear Medicine and Radiology, Centre Henri Becquerel and QuantIF (Litis EA4108 - FR CNRS 3638), Rouen, France.

Elena-Liana Veresezan (EL)

Department of Pathology, Centre Henri Becquerel, Rouen, France.

Fanny Drieux (F)

Department of Pathology, Centre Henri Becquerel, Rouen, France.

Pascaline Etancelin (P)

Department of Genetic Oncology, Centre Henri Becquerel, Rouen, France.

Sydney Dubois (S)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Aspasia Stamatoullas (A)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Hervé Tilly (H)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Elodie Bohers (E)

INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Fabrice Jardin (F)

Department of Hematology, Centre Henri Becquerel, Rouen, France.
INSERM U1245, Centre Henri Becquerel, University of Rouen, Rouen, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH